Dysregulated Cytokine Expression In Vivo in Prediseased and Diseased Autoimmune-Prone MRL Mice

References

• Sporn M. B., Roberts A. B. Peptide growth factors are multifunctional. Nature 1988; 332: 217–219
   PubMed Web of Science ®Google Scholar
• Nathan C., Sporn M. B. Cytokines in context. J. Cell Biol. 1991; 13: 981–986
   Google Scholar
• Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota, Cytokines T. Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 1990; 59: 783–786
   PubMed Web of Science ®Google Scholar
• Schwartz R. H. Costimulation of T lymphocytes: The role of CD28, CTLA‐4, and B7/BB1 in interleukin‐2 production and immunotherapy. Cell. 1992; 71: 1065–1068
   PubMed Web of Science ®Google Scholar
• Cytokines Cytokines D. E. In Systemic lupus erythematosus, A. D. Steinberg, moderator. Ann. Intern. Med. 1991; 115: 552–553
   Google Scholar
• Huang Y. P., Perrin L. H., Miescher P. A., Zubler R. H. Correlation of T and B cell activities in vitro and serum IL‐2 levels in systemic lupus erythematosus. J. Immunol. 1988; 141: 827–833
   PubMed Web of Science ®Google Scholar
• Malavé I., Searles R. P., Montano J., Williams R. C., Jr. Production of tumor necrosis factor/cachectin by peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Int. Arch. Allergy Appl. Immunol. 1989; 89: 355–361
   PubMedGoogle Scholar
• Maury C. P. J., Teppo A. M. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 1989; 32: 146–150
   PubMedGoogle Scholar
• Warrington R. J., Rutherford W. J. Normal mitogen‐induced suppression of the IL6 response and its deficiency in systemic lupus erythematosus. J. Clin. Immunol. 1990; 10: 52–60
   Google Scholar
• Linker‐Israeli M., Deans R. J., Wallace D. J., Prehn J., Ozeri‐Chen T., Klinenberg J. R. Elevated levels of endogenous IL‐6 in systemic lupus erythematosus: A putative role in pathogenesis. J. Immunol. 1991; 147: 117–123
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A. N., Dixon F. J. Murine models of systemic lupus erythematosus. Adv. Immunol. 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Cohen P. L., Eisenberg R. A. Lpr and gld Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 1991; 9: 243–269
   PubMed Web of Science ®Google Scholar
• Watanabe‐Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–317
   PubMed Web of Science ®Google Scholar
• Kroemer G., Martínez A. C. Cytokines and autoimmune disease. Clin. Immunol. Immunopath. 1991; 61: 275–295
   PubMedGoogle Scholar
• Boswell J. M., Yui M. A., Endres S., Burt D. W., Kelley V. E. Novel and enhanced IL‐1 gene expression in autoimmune mice with lupus. J. Immunol. 1988; 141: 118–124
   PubMed Web of Science ®Google Scholar
• Boswell J. M., Yui M. A., Burt D. W., Kelley V. E. Increased tumor necrosis factor and IL‐1β gene expression in the kidneys of mice with lupus nephritis. J. Immunol. 1988; 141: 3050–3054
   PubMed Web of Science ®Google Scholar
• Jacob C. O., McDevitt H. O. Tumor necrosis factor‐α in murine autoimmune lupus nephritis. Nature 1988; 331: 356–358
   PubMed Web of Science ®Google Scholar
• Brennan D. C., Yui M. A., Wuthrich R. P., Kelley V. E. Tumor necrosis factor and IL‐1 in New Zealand Black/White mice: Enhanced gene expression and acceleration of renal injury. J. Imnunol. 1989; 143: 3470–3475
   PubMed Web of Science ®Google Scholar
• Gordon C., Ranges G. E., Greenspan J. S., Wofsy D. Chronic therapy with recombinant tumor necrosis factor‐α in autoimmune NZB/NZW Fl mice. Clin. Immunol. Immunopath. 1989; 52: 421–434
   PubMedGoogle Scholar
• Satoh I., Seino H., Abo T., Tanaka S., Shintani S., Ohta S., Tamura K., Sawai T., Nobunaga T., Oteki T., Kumagai K., Toyota T. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 1989; 84: 1345–1348
   PubMed Web of Science ®Google Scholar
• Jacobs C., Young D., Callis G., Gillis S., Comlon P. J. In vivo treatment with IL‐1 reduces the severity and duration of antigen‐induced arthritis in rats. J. Immunol. 1988; 141: 2967–2974
   Google Scholar
• Hom J. T., Cole H., Bendele A. M. Interleukin 1 enhances the development of spontaneous arthritis in MRL/lpr mice. Clin. Immunol. Immunopathol. 1990; 55: 109–110
   Google Scholar
• Hom J., Bendele A. M., Carlson D. G. In vivo administration with IL‐1 accelerates the development of collagen‐induced arthritis in mice. J. Immunol. 1988; 141: 834–841
   PubMed Web of Science ®Google Scholar
• Cohen J. J. Programmed cell death in the immune system. Adv. Immunol. 1991; 50: 55–85
   PubMed Web of Science ®Google Scholar
• Donnelly R. P., Levine J., Hartwell D., Frendl G., Fenton M. J., Beller D. I. Aberrant regulation of IL‐l expression in macrophages from young autoimmune‐prone mice. J. Immunol. 1990; 145: 3231–3239
   PubMed Web of Science ®Google Scholar
• Levine J. S., Pugh B. J., Hartwell D., Fitzpatrick J. M., Marshak‐Rothstein A., Beller D. I. Interleukin‐1 dysregulation is an intrinsic defect in macrophages from MRL autoimmune‐prone mice. Eur. J. Immunol. 1993; 23: 2951–2958
   PubMedGoogle Scholar
• Magilvay D. B., Rothstein J. L. Spontaneous production of tumor necrosis factor a by Kupffer cells of MRL/lpr mice. J. Exp. Med. 1988; 168: 789–794
   Google Scholar
• Kelley V. E., Roths J. B. Increase in macrophage Ia expression in autoimmune mice: Role of the Ipr gene. J. Immunol. 1982; 129: 923–925
   PubMedGoogle Scholar
• Kofler R., Schreiber R. D., Dixon F. D., Theofilopoulos A. N. Macrophage I‐A/I‐E expression and macrophage‐stimulating lymphokines in murine lupus. Cell. Immunol. 1984; 87: 92–100
   PubMed Web of Science ®Google Scholar
• Jones F. S., Pisetsky D. S., Kurlander R. J. Defects in mononuclear phagocytic system (MPS) function in autoimmune MRL‐lpr/lpr mice. Clin. Immunol. Immunopath. 1985; 36: 30–39
   Google Scholar
• Yamashita U. Dysfunction of Ia‐positive antigen‐presenting cells in autoimmune mice. Cell. Immunol. 1986; 97: 257–266
   Google Scholar
• Rokutan K., Hosokawa T., Nakamura K., Koyama K., Aoike A., Kawai K. Increased superoxide anion production and glutathione peroxidase activity in peritoneal macrophages from autoimmune‐prone MRL/Mp‐lpd/lpr mice. Int. Arch. Allergy Appl. Immunol. 1988; 87: 113–119
   PubMedGoogle Scholar
• Santoro T. J., Morris D. H., Murphy R. C., Baker R. C. Aberrant production of leukotriene C4 by macrophages from autoimmune‐prone mice. J. Exp. Med. 1988; 168: 783–788
   Google Scholar
• Magilvay D. B., Rowley D. A., Davis M. The liver of MRL/lpr mice contains defective accessory cells and a population of immunosuppressive lymphocytes. Cell. Immunol. 1990; 125: 469–479
   Google Scholar
• Yui M. A., Brissette W. H., Brennan D. C., Wuthrich R. P., Rubin‐Kelley V. E. Increased macrophage‐colony stimulating factor in neonatal and adult autoimmune MRL‐1pr mice. Am. J. Path. 1991; 139: 255–261
   PubMed Web of Science ®Google Scholar
• Brennan D. C., Jevnikar A. M., Bloom R. D., Brissette W. H., Singer G. G., Kelley Rubin V. E. Cultured mesangial cells from autoimmune MRL‐lpr mice have decreased secreted and surface M‐CSF. Kidney Int. 1992; 42: 279–284
   Google Scholar
• Han J. H., Stratowa C., Rutter W. J. Isolation of full‐length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. Biochem. 1987; 26: 1617–1625
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1983; 32: 6–13
   Google Scholar
• Takacs L., Kovacs E. J., Smith M. R., Young H. A., Durum S. K. Detection of IL‐lα and IL‐1β gene expression by in situ hybridization: Tissue localization of IL‐1 mRNA in the normal C57B1/6 mouse. J. Immunol. 1988; 141: 3081–3095
   Google Scholar
• Chensue S. W., Terebuh P. D., Remick D. G., Scales W. E., Kunkel S. L. In vivo biologic and immunohistochemical analysis of interleukin‐1 alpha, beta and tumor necrosis factor during experimental endotoxemia: Kinetics, Kupffer cell expression, and glucocorticoid effects. Amer. J. Pathol. 1991; 138: 395–403
   Google Scholar
• Kroemer G., Cuende E., Martínez‐A C. Compartmentalization of the peripheral immune system. Adv. Immunol. 1993; 53: 157–216
   PubMed Web of Science ®Google Scholar
• Dinarello C. A. Interleukin‐1 and interleukin‐1 antagonism. Blood. 1991; 77: 1627–1652
   PubMed Web of Science ®Google Scholar
• Liu Y., Janeway C. A., Jr. Microbial induction of co‐stimulatory activity for CD4 T‐cell growth. Int. Immunol. 1991; 3: 323–332
   Google Scholar
• Adi S., Pollock A. S., Shigenaga J. K., Moser A. H., Feingold K. R., Grunfeld C. Role for monokines in the metabolic effect of endotoxin: Interferon‐γ restores responsiveness in C3H/HeJ mice. in vivo. J. Clin. Invest. 1992; 89: 1603–1609
   Google Scholar
• Ulich T. R., Guo K., Irwin B., Remick D. G., Davatelis G. N. Endotoxin‐induced cytokine gene expression. II. Regulation of tumor necrosis factor and interleukin‐1 α/β expression and suppression. Amer. J. Path. 1990; 137: 1173–1185
   PubMedGoogle Scholar
• Ulich T. R., Guo K., Yin S., del Castillo J., Yi E. S., Thompson R. C., Eisenberg S. P. Endotoxin‐induced cytokine gene expression. IV. Expression of interleukin‐1 α/β and interleukin‐I receptor antagonist mRNA during endotoxemia and during endotoxin‐initiated local acute inflammation. Amer. J. Path. 1992; 141: 61–68
   PubMed Web of Science ®Google Scholar
• Wollenberg G. K., Bolgos G., DeForge L. E., Remick D. G. Tumor necrosis factor and interleukin‐6 synthesis by peritoneal macrophages in vivo and in culture. FASEB J. 1993; 7: A712, (Abstr.)
   Google Scholar